|
Sep 8
|
Regeneron Announces Updates to Board of Directors
|
|
Sep 8
|
2 Top Biotech Stocks to Buy in September
|
|
Sep 7
|
Halozyme Therapeutics (HALO) Down 3.8% Since Last Earnings Report: Can It Rebound?
|
|
Sep 6
|
12 Best Healthcare ETFs To Buy
|
|
Aug 25
|
Is Regeneron Stock a Buy Now?
|
|
Aug 25
|
The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Gilead Sciences, Novavax, Apellis Pharmaceuticals and Fulcrum Therapeutics
|
|
Aug 24
|
Biotech Stock Roundup: REGN Up on Approval, APLS, NVAX Gain on Updates & More
|
|
Aug 23
|
Regeneron Announces Investor Conference Presentations
|
|
Aug 23
|
Health Care Roundup: Market Talk
|
|
Aug 23
|
Are Robust Financials Driving The Recent Rally In Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock?
|
|
Aug 22
|
UPDATE 1-US govt awards $1.4 bln for development of new COVID therapies, vaccines
|
|
Aug 22
|
Regeneron Announces Agreement with BARDA Supporting Development of Next-Generation Antibody Therapy for COVID-19 Prevention
|
|
Aug 21
|
Regeneron Hits A New Record High On The Approval That 'Could Not Come Soon Enough'
|
|
Aug 21
|
FDA Approves Regeneron's Drug For Ultra Rare Immune Disorder
|
|
Aug 21
|
Regeneron Pharmaceuticals Inc: A Deep Dive into Its Financial Metrics and Competitive Strengths
|
|
Aug 21
|
Regeneron (REGN) Gets FDA Nod for Higher Dose of Eylea
|
|
Aug 21
|
Regeneron Stock-Price Targets Rise as FDA Approves Higher Dose of Eye Drug
|
|
Aug 21
|
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
|
|
Jun 29
|
Regeneron to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on August 3, 2023
|
|
Jun 29
|
Why Regeneron Pharmaceuticals Stock Dipped This Week
|